Myeloproliferative disorder
A clonal hematopoietic stem cell disorder, characterized by proliferation in the bone marrow of one or more of the myeloid (i.e., granulocytic, erythroid, megakaryocytic, and mast cell) lineages. It is primarily a neoplasm of adults. (WHO 2008)
Disease Alternative Name
Ex.central Hospital Dhanbad.1985 ..1993..ex.pathologist .drs Tribedy and Roy Dianostic Lab.kolkata.ex Pathologist.inst of Child Health Kolkata.
Senior Pathologist
School of Tropical Medicine. Kolkata
d c p
Saveetha Medical College and Hospital, Chennai
Professor of Transfusion Medicine and Senior Consultant In Pathology
Kasturba Medical College
M.B.B.S
20 Years of Teaching To Both UGs & PGs
As Assistant, Associate & Professor
Gandhi Medical College, Dr. NTRUHS
MD Pathology
Dr. Potdar Laboratories
Pathologist
Wanless Hospital
M. D. Pathology
COMMUNITY HEALTH CENTER BAYTU
Principal Medical Officer
RNT MEDICAL COLLEGE UDAIPUR RAJASTHAN
MD MEDICINE
Government Hospital
Pathologist
Netaji Subhash Chandra Bose Medical College And Hospital
MBBS, DCP
Osmania Medical College
MD Pathology
Itahar BPHC
Medical Officer
IPGMER and SSKM
MD Pathology
Trending Diseases
Trending Cases
U-WIN launch in 100-day plan of next govt. Similar to the CoWIN portal for covid-19, the government's U-WIN platform registers and tracks routine vaccination and immunisation in India. Currently being run in a pilot mode in 2 districts of each state and union territory. Does such digital tracking help Govt. of India to perform timely immunisation, reduce dropout and get better insights about immunisation in Country? What do you think about it?
Doc Insights1 Like8 Answers- Login to View the image
Findings and Diagnosis Please.
Dr. Syam Sundar Patro1 Like7 Answers - Login to View the image
Congratulations to all the top performers of Quick Brains Quiz. Quiz date - 19th May 2024 Thank you all for your participation.
Curofy Quiz3 Likes6 Answers - Login to View the image
M.58yrs. Cough. 1month.
Dr. Syam Sundar Patro0 Like3 Answers - Login to View the image
Management of hypertension should include lifestyle modifications and single-pill combination therapy with RAS inhibitors, CCB, and diuretics. Due to overlapping pathophysiology and shared risk factors, co-morbidities often complicate hypertension. In this learning series post which may be helping with the doctor community to revisit important Hypertension related treatment scenario & insights.
Curofy Upskill5 Likes3 Answers